Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess

CRN04894 is an orally administered nonpeptide that is a potent and selective antagonist for adrenocorticotropic hormone (ACTH) acting at the melanocortin 2 receptor (MC2R) and is currently under development for the treatment of diseases of ACTH excess such as Cushing’s disease, congenital adrenal hy...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Fowler, Melissa A, Kusnetzow, Ana Karin, Han, Sangdon, Reinhart, Greg, Kim, Sun Hee, Johns, Michael, Kredel, Taylor A, Antwan, Agnes, Athanacio, Jon, Tsivkovski, Oleg, Luo, Rosa, Madan, Ajay, Zhu, Yun Fei, Betz, Stephen F, Struthers, Scott, Markison, Stacy
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2021
Предметы:
Adrenal
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090401/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.337
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы